Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 76.25m |
Free float | 68.05m |
P/E (TTM) | 9.11 |
Market cap | 1.20bn USD |
EPS (TTM) | 1.73 USD |
--
More ▼
Press releases
- InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
- InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
- InMode to Present at 2024 Baird Global Healthcare Conference
- InMode to Present at Upcoming Investor Conferences
- InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M
- InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
- DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer
- Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
- InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
More ▼